The drug being tested in this study is called TAK-850. This drug is being tested to evaluate the safety and immunogenicity of a single subcutaneous injection as compared to a single, intramuscular injection.~A total of 110 healthy participants (55 per group) will take part in this study.~Each participant will be randomly (like flipping a coin) assigned to receive one of the following :~A single injection of TAK-850, subcutaneously , or~A single injection of TAK-850, intramuscularly.~Participants will make up to 3 visits to the study site. Total duration of this study is 22 days.
The purpose of this study is to evaluate the safety and immunogenicity of a single subcutaneous injection of TAK-850 as compared to intramuscular injection of TAK-850 in healthy Japanese adults